|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||0.1437 - 0.1437|
|52-week range||0.1220 - 0.7550|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES GEORGETOWN, Ontario, Jan. 05, 2022 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62–103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues in connection with the filing of an early warning report by George Barakat in respect of the disposition of common shares in the capital of Jack Nathan Medical Corp. ("JNMC ") (TSXV:JNH.V). George
TORONTO, December 31, 2021--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited consolidated interim financial results for the third quarter of fiscal 2022, ended October 31, 2021. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 16th Life Sciences Virtual Investor Conference are now available for on-demand viewing.